Recursion CEO Chris Gibson is out after 12 years as the ambitious ‘techbio’ company positions itself for its next phase of AI drug discovery.
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
Progress on more than a dozen powerful new generative AI capabilities across the revenue cycle Pilot program already shows promising results of enhancing productivity by 5X and accuracy by more than 10% LEHI, Utah and […]
LINDON, Utah, Nov. 26, 2025 /PRNewswire/ — Trucordia, a top 20 U.S. insurance brokerage, today announced its acquisition of Breezy Seguros, a technology-driven and diversity-minded insurance business headquartered in Framingham, Massachusetts. With offices in Stoughton […]
USANA honored with five Best of State Awards SALT LAKE CITY, May 25, 2023 /PRNewswire/ — USANA, a leader in global nutrition, was honored at the Best of State Gala in Salt Lake City, Utah, […]
Copyright © 2026 Biotech Networks
